Network of New England
 Section 508 Compliance            + Larger Font | + Smaller Font            print this pagePrint This Page


About Us

annual report

Community Partners

conditins for coverage

CROWNWeb


data reporting

dialysis facility compare

emergency preparedness


Fistula First

5 Diamond

Grievance Policy

News Letters

Our Goals


patient advisory committee

patient services and community

quality improvement

Statistic Highlights

Voc Rehab state office

what's new

What's New in the ESRD Community in 2010

View previous years:
March 11, 2010
World Kidney Day (WKD)

Almost 400,000 Americans have kidney disease requiring dialysis treatments. Many more have the disease and don’t even know it. The 2010 campaign will focus on Diabetes, the leading cause of Chronic Kidney Disease. World Kidney Day (WKD) is a global health awareness campaign focusing on the importance of our kidneys and reducing the frequency and impact of kidney disease and its associated health problems worldwide.

Together, we can stop this disease from claiming so many lives. For more information about kidney disease, visit www.kidney.org or World Kidney Day, visit www.worldkidneyday.org

March 7 - 13, 2010
National Patient Safety Awareness Week (PSAW)

PSAW (March 7-13, 2010) is a national education and awareness-building campaign for improving patient safety at the local level. Healthcare organizations across the country are encouraged to plan events to promote patient safety within their own organizations. Educational activities are centered on educating patients on how to become involved in their own health care, as well as working to build partnerships with their patient community.

For mor information, and useful tools and resources, go to: http://www.npsf.org/hp/psaw/

March 2, 2010
FDA Classifies Baxter's January HomeChoice Peritoneal Dialysis Cycler Field Corrective Action as a Class I Recall
Baxter is Deploying Revised Labeling, Training and Upcoming Software Revisions to Further Assist Clinicians and Patients

Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall. This action has been classified as a Class I recall because of the risk of serious injury or patient death that could be associated with the use of this device. Over the last two years, Baxter has received serious injury reports and at least one patient death report associated with this issue.

Read more...

March 1, 2010
March is National Kidney Month!
Kidneys filter your blood. They remove wastes and extra water. When the kidneys are diseased, they stop doing these jobs and wastes build up, damaging the body. If not treated, kidney disease can lead to kidney failure. But you can prevent kidney failure.

Early kidney disease has no symptoms. Most people don't know something is wrong until their kidneys are about to fail. The only way to tell if you have kidney disease is to get tested. Simple blood and urine tests are used to detect kidney disease.

For more information, including patient videos & education and provider tools & resources, visit: http://www.nkdep.nih.gov/kidneymonth/

NKDEP is an initiative of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), U.S. Department of Health & Human Services (DHHS).

February 22, 2010
Join AAKP at its 37th Annual Convention

The American Association of Kidney Patients (AAKP) is pleased to announce the date and location of the 2010 Annual Convention in sunny Tampa, FL, September 2 - 4, 2010.

AAKP created its Annual Convention to provide kidney disease patients, as well as their friends and family members with the opportunity to discuss their concerns and share their experiences while learning about important issues affecting their health care. In addition to exciting social events, it is the largest national convention where kidney patients can interact on a person-to-person basis with fellow patients and health care professionals. During this three-day event, attendees participate in educational topics for those with chronic kidney disease (CKD) to long-term dialysis and transplant recipients. Participants also learn about various treatments for each stage.

For more information, visit http://www.aakp.org/events/convention/2010/

February 17, 2010
Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication
FDA and Amgen notified healthcare professionals and patients that all ESAs must be used under a REMS risk management program. As part of the risk management program, a Medication Guide explaining the risks and benefits of ESAs must be provided to all patients receiving an ESA. Under the ESA APPRISE Oncology program, Amgen will ensure that only those hospitals and healthcare professionals who have enrolled and completed training in the program will prescribe and dispense ESAs to patients with cancer.

Amgen is also required to oversee and monitor the program to ensure that hospitals and healthcare professionals are fully compliant with all aspects of the program. FDA is requiring a REMS because studies show that ESAs can increase the risk of tumor growth and shorten survival in patients with cancer who use these products. Studies also show that ESAs can increase the risk of heart attack, heart failure, stroke or blood clots in patients who use these drugs for other conditions.

Patients with chronic kidney failure (includes patients on dialysis and those not on dialysis) using ESAs should:
• Know that the use of ESAs can increase the risk for stroke, heart attack, heart failure, blood clots, and death.
• Read the Medication Guide to understand the benefits and risks of using an ESA.
• Get blood tests while using ESAs. The test results may help guide the course of therapy and lower the risks of using these drugs. Patients' healthcare professionals should make them aware of how often to have blood tests.
• Talk with their healthcare professional about any questions they have about the risks and benefits of using ESAs.

Read the complete MedWatch 2010 Safety summary including links to the Drug Safety Communication and current Prescribing Information for these products, at:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm200391.htm

February 9, 2010
National Kidney Foundation 2010 Spring Clinical Meetings (SCM10)

The National Kidney Foundation 2010 Spring Clinical Meetings will be taking place in Orlando, Florida from April 13 - 17, 2010.

SCM 10 presents a unique opportunity for busy renal health care providers to learn new developments related to all aspects of nephrology. It is designed for kidney doctors in the private sector and academia, fellows and residents with a special interest in kidney disease, general internists, pharmacists, physician assistants, nurse practitioners, nurses and technicians, social workers, and renal and clinical dietitians.

To register, simply visit http://www.kidney.org/news/meetings/clinical/index.cfm

January 29, 2010
Medicare Claims Data Will Have a New Required Quality Measure

Effective July 1, 2010, the Medicare (dialysis) in-facility claims billing submission will require the reporting of KT/V, vascular access type and infection. The URR will no longer be required. The hemoglobin lab value will continue to be reported.

To view the CMS Pub 100-04 Medicare Claims Processing notice addresing these changes, click here.

January 29, 2010
Bruit Audio Clips Available for Patient and Staff Education
A failing arteriovenous (AV) fistula places patients at risk for inadequate dialysis, which can lead to numerous complications and increased morbidity and mortality. Established AV fistulas require frequent routine monitoring to ensure continued patency and part of monitoring requires listening for the “bruit” -- the term for the unusual sound of blood flowing through the AV fistula from a high pressure (artery) to a low pressure (vein) channel.
Thanks to Tushar Vachharajani, MD, FACP, FASN, Associate Professor Internal Medicine/Nephrology, Wake Forest University Baptist Medical Center (www.wfubmc.edu/kidney), Winston-Salem, North Carolina, the Fistula First website now has audio clips of normal bruits, bruits with stenosis (narrowing in blood vessels) and bruits with whistles. Dr. Vachharajani describes, “A normal bruit is soft and continuous, and a high pitched bruit is due to the presence of stenosis and increased turbulence. A ‘whistle’ suggests a critical stenosis and should be evaluated immediately, I generally describe it as ‘wind blowing through a crack in a door’ and most patients and staff relate to the sound immediately.”

These sounds can teach hemodialysis patients and healthcare providers what to listen for when monitoring AV fistulas and AV grafts. Physical examinations should be performed at each dialysis treatment, using a stethoscope to assure the vascular access has blood flow.

Dr. Vachharajani uses the audio clips in the initial training for patient care technicians and nurses, as well as during a refresher course for all dialysis staff members. His patients are encouraged to perform a daily physical examination of their dialysis access and these sounds are used to teach them the difference between a normal and abnormal bruit. Dr. Vachharajani says, “I use these sounds to teach my fellows the nitty-gritty of nephrology practice,” and “these sounds are included in a one-day course for charge nurses.”

To listen to the bruit audio clips visit the FFBI website at www.fistulafirst.org under What’s New.

January 29, 2010
RECALL: Edwards Lifesciences Aquarius Hemodialysis System
FDA and Edwards Lifesciences notified healthcare professionals of a Class I recall of the Aquarius Hemodialysis System due to reports of clinically significant fluid imbalance and the potential for users to repeatedly override the fluid imbalance alarm. This could result in a decrease or increase in the volume of the circulating blood, which may result in serious injuries or death.

The recall includes model numbers: GEF08200, GEF09500, GEF09600, GEF09700, and GEF09800, using Software version 6.00.04. The product was distributed from July 12, 2007 through March 18, 2009. Baxter International, Inc. is the U.S. distributor of the Aquarius.

Read more...

January 25, 2010
RECALL: GlucoPro Insulin Syringes
Nipro Medical Corporation, Miami FL, is initiating a nationwide recall of all GlucoPro Insulin Syringes (This does not include the GlucoPro syringe specific for use with the Amigo Insulin pump).

These syringes may have needles that detach from the syringe. If the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection.

Consumers who have GlucoPro Insulin Syringes should stop using and return them to point of sale for reimbursement.

Read more...

January 13, 2010
New OSHA Videos Feature Guidance on Respirators
The Occupational Safety and Health Administration (OSHA) has developed two new videos for healthcare workers that feature training and guidance on respirator safety.

OSHA's "Respirator Safety" video demonstrates how to correctly put on and take off common types of respirators, such as N95s. "The Difference between Respirators and Surgical Masks" video explains how they prevent exposure to infectious diseases.

"Respirators play an important role in protecting many workers from exposure to chemical and biological hazards in the workplace," says Assistant Secretary of Labor for OSHA David Michaels. "At a time when pandemic influenza has highlighted the risk to healthcare workers, these videos will prepare and protect workers from the very illnesses they are responsible for treating."

The videos also explain how workers can perform a user seal check to test whether a respirator is worn properly and will provide the expected level of protection. Viewers may watch both English and Spanish versions by visiting OSHA's Respiratory Protection page or the Department of Labor's YouTube site.

According to OSHA's respiratory protection standard 29 CFR 1910.134, respirators must be used as part of a comprehensive respiratory protection plan.

http://www.osha.gov/SLTC/respiratoryprotection/index.html#trainingvideos
http://www.youtube.com/usdepartmentoflabor

January 13, 2010
RECALL: HomeChoice Automated PD System and HomeChoice PRO Automated PD System (Product Codes 5C4471, 5C4471R, 5C8310, 5C8310R)

Baxter recently sent an Urgent Device Correction letter to peritoneal dialysis clinician to help reduce or eliminate overfill, also referred to as Increased Intraperitonal Volume (IIPV), associated with HomeChoice/HomeChoice PRO cyclers. IIPV can result in serious injury or death from conditions including, but not limited to, hydrothorax, heart failure, pulmonary edema or pericardial effusion. Baxter has received complaints of IIPV, which resulted from patient use errors and/or prescription errors.

Read more...

January 5, 2010
CROWNWeb Six-Part WebEx Series

Start off the New Year with some answers to your CROWNWeb-related questions!

What is independent facilities’ perspective of the CROWNWeb system?

What is the latest on the Batch Data Submission process?

How are facilities using the CROWNWeb system in the REAL WORLD?

Join other renal community stakeholders, CMS and the Renal – Requirements, Communications and Training team (RCT) as we present the latest information related to the CROWNWeb system via a six-part WebEx series.

These sessions will be held the last Thursday of each month, January 28, 2010 - June 24, 2010; and will provide a means for the community to share thoughts regarding each topic.

Larry Emerson, President of the National Renal Administrators Association (NRAA), will kick-off this six-part WebEx series by discussing independent facilities’ overall perspective of the CROWNWeb system.

CROWNWeb six-part WebEx Series Schedule

Crown WebEx Schedule

Register for these WebEx sessions today! http://www.projectcrownweb.org/crown/presentations.php

January 4, 2010
WebeX Presentation: CQI and QAPI: What are They & Why Do We Need Them?

January 26, 2010
1:00 p.m. - 2:00 p.m. EST

Registration Form

Teleconference: 1-888-273-3658
Access Code: 4745702

Speaker: Karen Robbins, MS, RN, CNN - Educator Hartford Hospital Dialysis & Transplant Programs

Program Objectives:

  • Discuss how a QAPI will help improve process & clinical care
  • Expand your current knowledge base in improving QAPI programs
  • Discuss practical approaches to establishing a QAPI program

Please follow these instructions to join the event:

1) Click on or go to https://ifmcevents.webex.com
2) Locate your event
3) Click on the Join Now link to the right of the event or click on the name of the event
4) Enter your name and email address
5) Enter the Event Password: Network1
6) Click on Join
7) Dial the teleconference number. The number is 1-888-273-3658.

Please join us 15 minutes prior to the presentation to ensure the automatic system set-up has been properly established.

If you have any questions or problems accessing the meeting, please call the IFMC WebEx Helpline at 515-440-8555.

For information about participating in this WebEx, please call 203-387-9332 or email Peggy Lynch.



30 Hazel Terrace | Woodbridge, CT 06525 | Ph: 203-387-9332 | Fax: 203-389-9902 | info@nw1.esrd.net